Delivery Order SPE2DR25D2104-SPE2DR26F3USH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Nitazoxanide 500 mg tablets in quantities of six units. This firm fixed-price delivery order, valued at $3,512.48, represents a non-competitive set-aside and is scheduled for completion by November 6, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $27,816.49 delivery order to AmerisourceBergen Drug Corp for Nitazoxanide 500mg tablets (6 count) with a completion date of January 12, 2026. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle valued through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $12,378.20 to AmerisourceBergen Drug Corp for the supply of Nitazoxanide 500 mg tablets (quantity of six units) on December 9, 2025, with completion scheduled for December 10, 2025. The award is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive selection. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a delivery order valued at $6,189.10 to AmerisourceBergen Drug Corp for the supply of Nitazoxanide 500 mg tablets (quantity: 6 units) with a completion date of February 2, 2026. This is a firm fixed-price, non-set-aside contract awarded on January 30, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $92,949.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Nitazoxanide 500 mg tablets (quantity 6) on January 26, 2026, with an ultimate completion date of January 27, 2026. This competitively awarded contract, which carries no set-aside designation, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Nitazoxanide is an antiparasitic medication commonly used to treat various parasitic...
- The Defense Logistics Agency awarded a $3,477.04 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Nitazoxanide 500 mg tablets in quantities of six. The contract is firm fixed price with no set-aside designation and is scheduled for completion by August 14, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is registered in the System for Award...
- The Defense Logistics Agency awarded a $4,212.70 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for Nitazoxanide 500 mg tablets in quantities of six. This competitively awarded, non-set-aside contract is scheduled for ultimate completion on December 11, 2025, with performance at the vendor's Conshohocken, Pennsylvania location. The order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $32,047.25 delivery order to AmerisourceBergen Drug Corp for Nitazoxanide 500 mg tablets (6-count packages) on November 24, 2025, with completion scheduled for November 25, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Nitazoxanide is an antiparasitic medication commonly used to treat various parasitic and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 31, 2025, for the supply of Nitazoxanide 500 mg tablets in quantities of six units. This is a firm fixed price contract with a ceiling value of $26.5K and an ultimate completion date of January 2, 2026. The contract was awarded without a set-aside designation on a competitive basis and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,237.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 500 mg Nitazoxanide tablets (quantity 6) on January 29, 2026, with an ultimate completion date of January 30, 2026. This non-set-aside contract was performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Nitazoxanide is an antiprotozoal medication commonly used to treat parasitic infections and has applications within military and federal healthcare...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3USHDelivery Order
The Defense Logistics Agency awarded a $7,993.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the procurement of Nitazoxanide 500 mg tablets (6-count packaging). This contract, awarded on January 30, 2026, with an ultimate completion date of February 2, 2026, represents a child delivery order under AmerisourceBergen's parent company Cencora, Inc. The award carries no set-aside designation, indicating it was competitively awarded on a full and open basis. Performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under Cencora's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (valued at $999,999,999.00 through December 31, 2031), which serves as the primary procurement vehicle for pharmaceutical products and medical supplies supporting global military healthcare programs. AmerisourceBergen, as the prime contractor for this vehicle, maintains a comprehensive portfolio of pharmaceutical deliveries to federal medical procurement needs, particularly for military and veteran healthcare systems, positioning the company as a critical vendor within the Defense Health Agency supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 1/29/26 |